PubMed:33048372
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 60-66 | Body_part | denotes | Kidney | http://purl.org/sig/ont/fma/fma7203 |
T2 | 564-570 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
T3 | 1566-1572 | Body_part | denotes | kidney | http://purl.org/sig/ont/fma/fma7203 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 60-66 | Body_part | denotes | Kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T2 | 564-570 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
T3 | 1566-1572 | Body_part | denotes | kidney | http://purl.obolibrary.org/obo/UBERON_0002113 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 233-261 | Disease | denotes | systemic lupus erythematosus | http://purl.obolibrary.org/obo/MONDO_0007915 |
T2 | 242-261 | Disease | denotes | lupus erythematosus | http://purl.obolibrary.org/obo/MONDO_0004670 |
T3 | 263-266 | Disease | denotes | SLE | http://purl.obolibrary.org/obo/MONDO_0007915 |
T4 | 272-283 | Disease | denotes | scleroderma | http://purl.obolibrary.org/obo/MONDO_0019340 |
T5 | 358-366 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 598-601 | Disease | denotes | SLE | http://purl.obolibrary.org/obo/MONDO_0007915 |
T7 | 605-616 | Disease | denotes | scleroderma | http://purl.obolibrary.org/obo/MONDO_0019340 |
T8 | 766-769 | Disease | denotes | MPA | http://purl.obolibrary.org/obo/MONDO_0019124 |
T9 | 821-824 | Disease | denotes | MPA | http://purl.obolibrary.org/obo/MONDO_0019124 |
T10 | 1094-1105 | Disease | denotes | arrhythmias | http://purl.obolibrary.org/obo/MONDO_0007263 |
T11 | 1193-1196 | Disease | denotes | MPA | http://purl.obolibrary.org/obo/MONDO_0019124 |
T12 | 1256-1267 | Disease | denotes | arrhythmias | http://purl.obolibrary.org/obo/MONDO_0007263 |
T13 | 1319-1331 | Disease | denotes | pancytopenia | http://purl.obolibrary.org/obo/MONDO_0001529 |
T14 | 1669-1680 | Disease | denotes | arrhythmias | http://purl.obolibrary.org/obo/MONDO_0007263 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 60-66 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | Kidney |
T2 | 60-66 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | Kidney |
T3 | 60-66 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | Kidney |
T4 | 564-570 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T5 | 564-570 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T6 | 564-570 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
T7 | 973-976 | http://purl.obolibrary.org/obo/CLO_0001562 | denotes | a 2 |
T8 | 973-976 | http://purl.obolibrary.org/obo/CLO_0001563 | denotes | a 2 |
T9 | 1566-1572 | http://purl.obolibrary.org/obo/UBERON_0002113 | denotes | kidney |
T10 | 1566-1572 | http://www.ebi.ac.uk/efo/EFO_0000927 | denotes | kidney |
T11 | 1566-1572 | http://www.ebi.ac.uk/efo/EFO_0000929 | denotes | kidney |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 171-183 | Chemical | denotes | antimalarial | http://purl.obolibrary.org/obo/CHEBI_38068 |
T2 | 184-188 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T3 | 289-298 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T4 | 474-488 | Chemical | denotes | pharmaceutical | http://purl.obolibrary.org/obo/CHEBI_52217 |
T5 | 730-740 | Chemical | denotes | tacrolimus | http://purl.obolibrary.org/obo/CHEBI_61049|http://purl.obolibrary.org/obo/CHEBI_61057 |
T7 | 742-745 | Chemical | denotes | Tac | http://purl.obolibrary.org/obo/CHEBI_61049 |
T8 | 747-764 | Chemical | denotes | mycophenolic acid | http://purl.obolibrary.org/obo/CHEBI_168396 |
T9 | 760-764 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T10 | 766-769 | Chemical | denotes | MPA | http://purl.obolibrary.org/obo/CHEBI_6716|http://purl.obolibrary.org/obo/CHEBI_138016|http://purl.obolibrary.org/obo/CHEBI_168396 |
T13 | 771-781 | Chemical | denotes | prednisone | http://purl.obolibrary.org/obo/CHEBI_8382 |
T14 | 783-787 | Chemical | denotes | Pred | http://purl.obolibrary.org/obo/CHEBI_8382 |
T15 | 799-804 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T16 | 817-820 | Chemical | denotes | Tac | http://purl.obolibrary.org/obo/CHEBI_61049 |
T17 | 821-824 | Chemical | denotes | MPA | http://purl.obolibrary.org/obo/CHEBI_6716|http://purl.obolibrary.org/obo/CHEBI_138016|http://purl.obolibrary.org/obo/CHEBI_168396 |
T20 | 825-829 | Chemical | denotes | Pred | http://purl.obolibrary.org/obo/CHEBI_8382 |
T21 | 910-915 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T22 | 1009-1012 | Chemical | denotes | ECG | http://purl.obolibrary.org/obo/CHEBI_70255 |
T23 | 1189-1192 | Chemical | denotes | Tac | http://purl.obolibrary.org/obo/CHEBI_61049 |
T24 | 1193-1196 | Chemical | denotes | MPA | http://purl.obolibrary.org/obo/CHEBI_6716|http://purl.obolibrary.org/obo/CHEBI_138016|http://purl.obolibrary.org/obo/CHEBI_168396 |
T27 | 1197-1201 | Chemical | denotes | Pred | http://purl.obolibrary.org/obo/CHEBI_8382 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1 | 0-18 | Chemical | denotes | Hydroxychloroquine | MESH:D006886 |
37 | 140-158 | Chemical | denotes | Hydroxychloroquine | MESH:D006886 |
38 | 160-163 | Chemical | denotes | HCQ | MESH:D006886 |
39 | 233-261 | Disease | denotes | systemic lupus erythematosus | MESH:D008180 |
40 | 263-266 | Disease | denotes | SLE | MESH:D008180 |
41 | 272-283 | Disease | denotes | scleroderma | MESH:C543759 |
42 | 310-313 | Chemical | denotes | HCQ | MESH:D006886 |
43 | 358-366 | Disease | denotes | COVID-19 | MESH:C000657245 |
44 | 533-536 | Chemical | denotes | HCQ | MESH:D006886 |
45 | 598-601 | Disease | denotes | SLE | MESH:D008180 |
46 | 605-616 | Disease | denotes | scleroderma | MESH:C543759 |
47 | 730-740 | Chemical | denotes | tacrolimus | MESH:D016559 |
48 | 742-745 | Chemical | denotes | Tac | MESH:D016559 |
49 | 747-764 | Chemical | denotes | mycophenolic acid | MESH:D009173 |
50 | 766-769 | Chemical | denotes | MPA | MESH:D009173 |
51 | 771-781 | Chemical | denotes | prednisone | MESH:D011241 |
52 | 783-787 | Chemical | denotes | Pred | MESH:D011241 |
53 | 817-820 | Chemical | denotes | Tac | MESH:D016559 |
54 | 821-824 | Chemical | denotes | MPA | MESH:D009173 |
55 | 825-829 | Chemical | denotes | Pred | MESH:D011241 |
56 | 830-833 | Chemical | denotes | HCQ | MESH:D006886 |
57 | 873-876 | Chemical | denotes | HCQ | MESH:D006886 |
58 | 965-968 | Chemical | denotes | HCQ | MESH:D006886 |
59 | 1016-1031 | Disease | denotes | QT prolongation | MESH:D008133 |
60 | 1082-1105 | Disease | denotes | ventricular arrhythmias | MESH:D001145 |
61 | 1189-1192 | Chemical | denotes | Tac | MESH:D016559 |
62 | 1193-1196 | Chemical | denotes | MPA | MESH:D009173 |
63 | 1202-1205 | Chemical | denotes | HCQ | MESH:D006886 |
64 | 1244-1267 | Disease | denotes | ventricular arrhythmias | MESH:D001145 |
65 | 1319-1331 | Disease | denotes | pancytopenia | MESH:D010198 |
66 | 1423-1426 | Chemical | denotes | HCQ | MESH:D006886 |
67 | 1437-1440 | Chemical | denotes | HCQ | MESH:D006886 |
68 | 1507-1512 | Disease | denotes | death | MESH:D003643 |
69 | 1516-1529 | Disease | denotes | graft failure | MESH:D006333 |
70 | 1531-1534 | Chemical | denotes | HCQ | MESH:D006886 |
71 | 1669-1680 | Disease | denotes | arrhythmias | MESH:D001145 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-89 | Sentence | denotes | Hydroxychloroquine and Maintenance Immunosuppression Use in Kidney Transplant Recipients: |
T2 | 90-113 | Sentence | denotes | Analysis of Linked U.S. |
T3 | 114-139 | Sentence | denotes | Registry and Claims Data. |
T4 | 140-284 | Sentence | denotes | Hydroxychloroquine (HCQ) is an antimalarial drug with immunomodulatory effects used to treat systemic lupus erythematosus (SLE) and scleroderma. |
T5 | 285-410 | Sentence | denotes | The antiviral effects of HCQ have raised attention in the context of the COVID-19 pandemic, although safety is controversial. |
T6 | 411-638 | Sentence | denotes | We examined linkages of national transplant registry data with pharmaceutical claims and Medicare billing claims to study HCQ use among Medicare-insured kidney transplant recipients with SLE or scleroderma (2008-2017; N=1,820). |
T7 | 639-726 | Sentence | denotes | We compared three groups based on immunosuppression regimen 7-12 months posttransplant: |
T8 | 727-884 | Sentence | denotes | 1) tacrolimus (Tac)+mycophenolic acid (MPA)+prednisone (Pred) (referent group, 77.7%); 2) Tac+MPA+Pred+HCQ (16.5%); or 3) other immunosuppression+HCQ (5.7%). |
T9 | 885-1188 | Sentence | denotes | Compared to the referent group, recipients treated with other immunosuppression+HCQ had a 2-fold increased risk of abnormal ECG or QT prolongation (18.9% vs. 10.7%; aHR,1.12 1.963.42 , p=0.02) and ventricular arrhythmias (15.2% vs. 11.4%; aHR,1.00 1.813.29 , p=0.05) in the >1-to-3 years posttransplant. |
T10 | 1189-1427 | Sentence | denotes | Tac+MPA+Pred+HCQ was associated with increased risk of ventricular arrhythmias (13.5% vs. 11.4%; aHR,1.02 1.54 2.31 , p=0.04) and pancytopenia (35.9% vs. 31.4%; aHR,1.03 1.311.68 , p=0.03) compared to triple immunosuppression without HCQ. |
T11 | 1428-1530 | Sentence | denotes | However, HCQ-containing regimens were not associated with an increased risk of death or graft failure. |
T12 | 1531-1694 | Sentence | denotes | HCQ may be used safely in selected kidney transplant recipients in addition to their maintenance immunosuppression, although attention to arrhythmias is warranted. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 233-261 | Phenotype | denotes | systemic lupus erythematosus | http://purl.obolibrary.org/obo/HP_0002725 |
T2 | 263-266 | Phenotype | denotes | SLE | http://purl.obolibrary.org/obo/HP_0002725 |
T3 | 272-283 | Phenotype | denotes | scleroderma | http://purl.obolibrary.org/obo/HP_0100324 |
T4 | 598-601 | Phenotype | denotes | SLE | http://purl.obolibrary.org/obo/HP_0002725 |
T5 | 605-616 | Phenotype | denotes | scleroderma | http://purl.obolibrary.org/obo/HP_0100324 |
T6 | 1000-1012 | Phenotype | denotes | abnormal ECG | http://purl.obolibrary.org/obo/HP_0003115 |
T7 | 1082-1105 | Phenotype | denotes | ventricular arrhythmias | http://purl.obolibrary.org/obo/HP_0004308 |
T8 | 1244-1267 | Phenotype | denotes | ventricular arrhythmias | http://purl.obolibrary.org/obo/HP_0004308 |
T9 | 1319-1331 | Phenotype | denotes | pancytopenia | http://purl.obolibrary.org/obo/HP_0001876 |
T10 | 1669-1680 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
hydroxychloroquine
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 233-261 | Phenotype | denotes | systemic lupus erythematosus | http://purl.obolibrary.org/obo/HP_0002725 |
T2 | 263-266 | Phenotype | denotes | SLE | http://purl.obolibrary.org/obo/HP_0002725 |
T3 | 272-283 | Phenotype | denotes | scleroderma | http://purl.obolibrary.org/obo/HP_0100324 |
T4 | 598-601 | Phenotype | denotes | SLE | http://purl.obolibrary.org/obo/HP_0002725 |
T5 | 605-616 | Phenotype | denotes | scleroderma | http://purl.obolibrary.org/obo/HP_0100324 |
T6 | 1000-1012 | Phenotype | denotes | abnormal ECG | http://purl.obolibrary.org/obo/HP_0003115 |
T7 | 1082-1105 | Phenotype | denotes | ventricular arrhythmias | http://purl.obolibrary.org/obo/HP_0004308 |
T8 | 1244-1267 | Phenotype | denotes | ventricular arrhythmias | http://purl.obolibrary.org/obo/HP_0004308 |
T9 | 1319-1331 | Phenotype | denotes | pancytopenia | http://purl.obolibrary.org/obo/HP_0001876 |
T10 | 1669-1680 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |